Skip to main content
Print Save

Micocilen Antifungal

Medically reviewed by Drugs.com. Last updated on Feb 22, 2021.

Dosage form: liquid
Ingredients: Undecylenic Acid 250mg in 1mL
Labeler: Arymar Inc.
NDC Code: 70570-0199

Micocilen
Antifungal

Drug Facts

Active Ingredient

Undecilenic Acid 25%

Purpose

Fungicida

Uses

For the cure of most

  • ringworm (tinea corporis)
  • athletes foot (tinea pedis)

Warnings

For external use only. If pregnant or breastfeeding consult a healthcare professional before use.

Do not use on children under 12 years of age unless directed by a Doctor. Avoid contact with eyes.

Use only as directed by a Doctor on persons with high sensitive skin.

Directions

Wash the affected area and dry thoroughly

  • apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product

Other Information

Keep Tightly closed when not in use. Store away from excessive heat and cold

Inactive Ingredients

Tea Tree Oil, Isopropyl Alcohol

PRINCIPAL DISPLAY PANEL - 29.5 ml Vial Carton

Arymar

Micocilen

Antifungal
Liquid

  • Easy to Apply
  • Dries Quickly, Non-Oily
    Formula

Net Cont. 1 Fl. Oz.
(29.5 ml)

Arymar

MICOCILEN   ANTIFUNGAL
undecylenic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70570-0199
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Undecylenic Acid (Undecylenic Acid) Undecylenic Acid250 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Tea Tree Oil 
Isopropyl Alcohol 
Packaging
#Item CodePackage Description
1NDC:70570-0199-11 VIAL, GLASS in 1 CARTON
129.5 mL in 1 VIAL, GLASS
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart333C03/01/2014
Labeler - Arymar Inc. (021650273)

Document Id: 80e228ba-5930-4e93-b669-929e6d2e2b42
Set id: a82067f0-4822-4de2-9f8f-5cf41e400109
Version: 2
Effective Time: 20190304
 
Arymar Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer